Koers Tetra Bio-Pharma Inc. Toronto S.E.
Aandelen
TBP
CA88166Y1007
Farmaceutische producten
Omzet 2020 | - | Omzet 2021 | - | Marktkapitalisatie | 88,81 mln. 122 mln. 82,5 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -26 mln. -35,58 mln. -24,15 mln. | Nettowinst (verlies) 2021 | -52 mln. -71,15 mln. -48,31 mln. | EV/omzet 2020 | - |
Nettoliquiditeiten 2020 | 501K 685K 465K | Nettoliquiditeiten 2021 | 1,77 mln. 2,43 mln. 1,65 mln. | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-1,86
x | K/w-verhouding 2021 |
-1,7
x | Werknemers | 33 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 99,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Catherine Auld
BRD | Director/Board Member | - | 28-05-21 |
H. Norton
CHM | Chairman | 63 | 17-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,35% | 6,32 mld. | |
-15,99% | 4,49 mld. | |
-6,35% | 3,3 mld. | |
+4,87% | 3,19 mld. | |
-0,53% | 2,6 mld. | |
+53,07% | 2,05 mld. | |
-3,63% | 1,77 mld. | |
+2,76% | 1,7 mld. | |
-8,02% | 1,63 mld. |